Medicare Enrolled
Dr. Kellie Lane, M.D.
Cardiovascular Disease · Augusta, GA
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lane
Dr. Kellie Lane is a cardiovascular disease specialist in Augusta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lane performed 2,079 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lane received a total of $9,414 from 28 pharmaceutical and/or device companies across 234 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 2,079 Medicare services
$9,414 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,079
Medicare services
Bottom 49% in GA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
591 | $81 | $370 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
392 | $47 | $252 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
143 | $11 | $73 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
117 | $59 | $249 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
106 | $10 | $51 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
99 | $51 | $271 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
99 | $6 | $35 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
80 | $44 | $194 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $123 | $561 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
66 | $94 | $468 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 40 | $234 | $948 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
35 | $15 | $77 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $17 | $78 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
29 | $2 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $62 | $253 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $89 | $355 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
26 | $19 | $96 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
21 | $1,098 | $5,515 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
18 | $53 | $293 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
16 | $5 | $28 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
15 | $75 | $890 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
13 | $10 | $137 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $137 | $496 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
19.6% high complexity
19.9% medium
60.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,414
Total received (2018-2024)
Avg $1,345/year across 7 years
Top 22% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
234
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$747
2023
$682
2022
$416
2021
$358
2020
$133
2019
$3,429
2018
$3,649
Payments by company (2024)
Amgen Inc.
$219
Novo Nordisk Inc
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Novartis Pharmaceuticals Corporation
$57
Janssen Pharmaceuticals, Inc
$54
PFIZER INC.
$54
Lexicon Pharmaceuticals, Inc.
$54
SCPHARMACEUTICALS INC.
$46
SANOFI-AVENTIS U.S. LLC
$28
Boston Scientific Corporation
$22
Merck Sharp & Dohme LLC
$21
AstraZeneca Pharmaceuticals LP
$15
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$5,511
Amgen Inc.
$491
Novartis Pharmaceuticals Corporation
$459
PFIZER INC.
$423
Janssen Pharmaceuticals, Inc
$356
Boehringer Ingelheim Pharmaceuticals, Inc.
$311
Novo Nordisk Inc
$252
Astellas Pharma US Inc
$201
SANOFI-AVENTIS U.S. LLC
$171
Inari Medical, Inc.
$160
AstraZeneca Pharmaceuticals LP
$151
Boston Scientific Corporation
$140
Merck Sharp & Dohme LLC
$111
Lexicon Pharmaceuticals, Inc.
$99
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$99
iRhythm Technologies, Inc.
$96
E.R. Squibb & Sons, L.L.C.
$68
Philips Electronics North America Corporation
$54
ARBOR PHARMACEUTICALS, INC.
$49
SCPHARMACEUTICALS INC.
$46
Gilead Sciences, Inc.
$31
Axsome Therapeutics, Inc.
$29
Esperion Therapeutics, Inc.
$24
Kiniksa Pharmaceuticals, Ltd.
$21
Bayer HealthCare Pharmaceuticals Inc.
$18
Amarin Pharma Inc.
$16
Kiniksa Pharmaceuticals International, plc
$15
Baxter Healthcare
$14
Top 3 companies account for 68.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · Arcalyst · BOSENTAN TABLETS · BRILINTA · Bidil · CHANTIX · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · Edarbi · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Hillrom - Carnation Ambulatory Monitor · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · Micra · NEXLETOL · Ozempic · PRADAXA · PRALUENT · Ranexa · Repatha · Rybelsus · S · SelectSecure · Sunosi · VERQUVO · VYNDAMAX · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
55
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
PIEDMONT AUGUSTA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lane is a cardiac & cardiac specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lane experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lane performed 591 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lane receive payments from pharmaceutical companies?
Yes. Dr. Lane received a total of $9,414 from 28 companies across 234 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lane's costs compare to other cardiologists in Augusta?
Dr. Lane's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Augusta
Browse cardiologists in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in GA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in GA
Which GA cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology